Evolus (EOLS) Debt to Equity (2017 - 2026)

Evolus (EOLS) reported Debt to Equity of -$5.43 for Q1 2026, up 70.54% on a YoY basis from -$3.19 in Q1 2025, and up 14.05% quarter-over-quarter from -$6.32 in Q4 2025.

Evolus (EOLS) Debt to Equity (2017 - 2026) Analysis & Trends

Evolus has reported Debt to Equity for 10 years, with the latest figure at -$5.43 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity rose 70.54% year-over-year to -$5.43; the trailing twelve-month figure through Mar 2026 stood at -$5.43 (up 70.54% YoY), and the FY2025 full-year result was -$6.32, down 128.74% from the prior year.
  • Debt to Equity for Q1 2026 stood at -$5.43, up from -$6.32 in the prior quarter.
  • The five-year high for Debt to Equity was $22.0 in Q4 2024, with the low at -$18.44 in Q1 2025.
  • Historically, Debt to Equity has averaged $0.43 across 5 years, with a median of $1.06 in 2022.
  • The largest YoY upside for Debt to Equity was 876.75% in 2023 against a maximum downside of 992.03% in 2023.
  • Evolus' Debt to Equity stood at $3.89 in 2022, then tumbled by 249.72% to -$5.82 in 2023, then jumped by 478.24% to $22.0 in 2024, then plunged by 128.74% to -$6.32 in 2025, then increased by 14.05% to -$5.43 in 2026.
  • The last three Debt to Equity figures came in at -$5.43 (Q1 2026), -$6.32 (Q4 2025), and -$5.07 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.02
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.80
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.61
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.86
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.47
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn -5.43

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.43
Dec 31, 2025 -6.32
Sep 30, 2025 -5.07
Jun 30, 2025 -7.80
Mar 31, 2025 -18.44
Dec 31, 2024 22.00
Sep 30, 2024 20.58
Jun 30, 2024 6.26
Mar 31, 2024 6.54
Dec 31, 2023 -5.82
Sep 30, 2023 -4.91
Jun 30, 2023 -13.62
Mar 31, 2023 10.37
Dec 31, 2022 3.89
Sep 30, 2022 2.45
Jun 30, 2022 1.53
Mar 31, 2022 1.06
Dec 31, 2021 0.87
Dec 31, 2020 -1.02
Sep 30, 2020 2.11